Tag: peripheral arterial disease

IVL

Cardiovascular Systems announces development of IVL technology for the treatment of coronary and peripheral arterial diseases

Cardiovascular Systems recently announced that it has made significant progress towards the commerci...

VIVA 2021: Consensus established for appropriate use of IVUS in peripheral interventions

A worldwide committee of 40 cross-specialty medical experts achieved the first-ever consensus fo...

ACC 2021: VOYAGER-PAD analysis shows totality of ischaemic events reduced following rivaroxaban use

Rupert Bauersachs (Darmstadt, Germany) talks to Cardiovascular News about the VOYAGER-PAD trial,...

New guideline: ASA no longer recommended to prevent first stroke, heart disease

A new Heart & Stroke guideline published today in the Canadian Medical Association Journal does ...

Positive NICE recommendation for Xarelto to prevent atherothrombotic events in CAD and PAD patients

The National Institute for Health and Care Excellence (NICE) has published the final appraisal deter...

Two-year MAJESTIC data show sustained positive results for Eluvia drug-eluting stent

The MAJESTIC trial set out to evaluate the performance of the Eluvia paclitaxel-eluting vascular ste...